Jenburkt Pharmaceuticals Ltd

NSE: JENBURPH · BSE: 524731 · Pharmaceuticals & Biotechnology · 16 announcements

Share price: ₹892.10
Market cap: ₹393.7 Cr
Revenue (annual): ₹168.7 Cr
Net profit (annual): ₹34.74 Cr
P/E (TTM): 12.0×Sector 47.4×
Promoter holding: 46.62%-0.02% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Financial Results 4 Management Change 2 Board Meeting Date 2 Annual General Meeting 2 Dividend 1 Debt & Borrowing 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

14 Apr 2026 13:18 IST BSE

Debt & Borrowing

Jenburkt Pharmaceuticals Debt & Borrowing

Jenburkt Pharmaceuticals Limited confirmed it does not meet the 'large corporate' criteria for the financial year ended March 31, 2026. This disclosure complies with SEBI's framework for debt-raising norms. The company is not currently subject to the mandatory incremental borrowing requirements applicable to large corporates.

Read the filing ↗